Thursday, July 9, 2026
ADVT 
National

Lululemon says Omicron impacting sales, profits

Darpan News Desk The Canadian Press, 10 Jan, 2022 04:54 PM
  • Lululemon says Omicron impacting sales, profits

VANCOUVER - Lululemon Athletica Inc. is lowering its fourth-quarter earnings estimates as the Omicron variant curbs the retailer's sales.

The Vancouver-based company says it now expects its net revenue and earnings to be on the low end of previously announced ranges.

Calvin McDonald, CEO of the athletic apparel retailer, says Lululemon started the holiday season in a strong position.

But he says the company has since experienced several consequences as a result of the surge in COVID-19 cases and changing restrictions.

He says Lululemon has been impacted by increased capacity constraints in stores, more limited staff availability and reduced operating hours in some locations.

David Swartz, an equity analyst at Morningstar, says Lululemon has consistently smashed sales and earnings expectations over the past three years, making it surprising to see any weakness emerge.

While he says one mild earnings miss does not materially impact valuation, the financial services firm has long had concerns that Lululemon is significantly overvalued

In a client note last March, Morningstar said Lululemon’s valuation "is as stretched as its leggings."

Lululemon’s share price dropped a little more than six per cent following Monday's announcement, and was down roughly 30 per cent from its all-time high in November.

The company's shares were trading for about US$333.30 midday on the Nasdaq composite. Swartz says Morningstar's fair value estimate is US$193.

Lululemon says it expects the company’s net revenue to be toward the low end of its range of US$2.125 billion to US$2.165 billion.

It expects diluted earnings per share and adjusted diluted earnings per share to be toward the low end of its ranges of US$3.24 to US$3.31 and US$3.25 to US$3.32, respectively.

MORE National ARTICLES

Missing man found dead in Manning Park: police

Missing man found dead in Manning Park: police
Fendrikov, described by police as an avid hiker with significant backcountry experience, was reported missing earlier this week when he did not show up for work.

Missing man found dead in Manning Park: police

Indigenous tourism faces tough pandemic recovery

Indigenous tourism faces tough pandemic recovery
A report from the association and the Conference Board of Canada shows modest recovery over the last year, but it still projects an overall 54 per cent decline since the pandemic hit last March.

Indigenous tourism faces tough pandemic recovery

VPD searches for witness to frightening Yaletown collision

VPD searches for witness to frightening Yaletown collision
Investigators believe the collision was caused by an impaired driver who went the wrong way down Richards Street, before striking a tree and crashing through a construction fence near Richards and Pacific around 11 a.m.

VPD searches for witness to frightening Yaletown collision

Killed a family: Mass murderer seeking parole

Killed a family: Mass murderer seeking parole
David Shearing, who now goes by the name David Ennis, shot and killed George and Edith Bentley; their daughter, Jackie; and her husband, Bob Johnson, while the family was on a camping trip in the Clearwater Valley near Wells Gray Provincial Park, about 120 kilometres north of Kamloops, B.C., in 1982.    

Killed a family: Mass murderer seeking parole

Leaders talk affordability in push for votes

Leaders talk affordability in push for votes
The country's headline inflation figure registered an annual increase of 4.1 per cent in August, fuelled by rising demand as more parts of the economy reopened amid supply-chain constraints for many goods.

Leaders talk affordability in push for votes

Providence's mRNA vaccine to be made in Winnipeg

Providence's mRNA vaccine to be made in Winnipeg
The company says it has signed a $90-million, five-year contract with Emergent Biosolutions to make part of the drug substance, and also to fill and finish the vaccine, at its Winnipeg manufacturing plant.

Providence's mRNA vaccine to be made in Winnipeg